FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 50% Injection
Status: Resolved
»Duration of Shortage: 04/27/2017 - 02/09/2021
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Revised 02/09/2021)

Company Contact Information:
800-423-4136

Presentation
  • DEXTROSE INJECTION, USP, 50%, [500 mg / mL](NDC 76329-3301-1)
Note:
  • N/A

Hospira, Inc. (Revised 02/09/2021)

Company Contact Information:
844-646-4398

Presentation
  • 25 g/50 mL (50%; 0.5 g/mL); LifeShield Abboject Glass Syringe (NDC 0409-4902-34)
  • 25 g/50 mL (50%; 0.5 g/mL); Single Dose Glass Fliptop Vial (NDC 0409-6648-02)
  • 25 g/50 mL (50%; 0.5 g/mL); Ansyr Plastic Syringe (NDC 0409-7517-16)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English